This regulation grants fee remission for certain medical device establishment licence applications or annual reviews submitted during the COVID-19 pandemic, specifically for applications examined between April 1, 2020, and December 31, 2021, and cancelled by January 31, 2022, provided the fee was not previously paid. The remission applies to the applicable fee and any interest, and the Order comes into force upon registration.